Evidence map›Paper›PMID 33423661›Full record

ArticleBMC psychiatry2021

Systematic content analysis of patient evaluations of START NOW psychotherapy reveals practical strategies for improving the treatment of opioid use disorder.

Albert Yi-Que Truong, Brian Fabian Saway, Malek H Bouzaher, Mustafa Nawroz Rasheed, Sanaz Monjazeb, Soleille Dorothy Everest, Susan Linda Giampalmo, David Hartman, Cheryl Hartman, Anita S Kablinger and 1 more

Open access · goldAbstract read
In one paragraph

Article in BMC psychiatry, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
1.6field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 1 institution in 1 country.

Albert Yi-Que TruongVirginia Tech Carilion School of Medicine, 2 Riverside Circle, Roanoke, VA, 24016, USA.
Brian Fabian SawayVirginia Tech Carilion School of Medicine, 2 Riverside Circle, Roanoke, VA, 24016, USA.
Malek H BouzaherVirginia Tech Carilion School of Medicine, 2 Riverside Circle, Roanoke, VA, 24016, USA.
Mustafa Nawroz RasheedVirginia Tech Carilion School of Medicine, 2 Riverside Circle, Roanoke, VA, 24016, USA.
Sanaz MonjazebVirginia Tech Carilion School of Medicine, 2 Riverside Circle, Roanoke, VA, 24016, USA.
Soleille Dorothy EverestVirginia Tech Carilion School of Medicine, 2 Riverside Circle, Roanoke, VA, 24016, USA.
Susan Linda GiampalmoVirginia Tech Carilion School of Medicine, 2 Riverside Circle, Roanoke, VA, 24016, USA.
David HartmanVirginia Tech Carilion School of Medicine, 2 Riverside Circle, Roanoke, VA, 24016, USA.
Cheryl HartmanVirginia Tech Carilion School of Medicine, 2 Riverside Circle, Roanoke, VA, 24016, USA.
Anita S KablingerVirginia Tech Carilion School of Medicine, 2 Riverside Circle, Roanoke, VA, 24016, USA.
Robert L TrestmanVirginia Tech Carilion School of Medicine, 2 Riverside Circle, Roanoke, VA, 24016, USA. rltrestman@carilionclinic.org.ORCID 0000-0003-0168-8057
Carilion Clinic · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundClinical trials provide consistent evidence for buprenorphine's efficacy in treating opioid use disorder (OUD). While the Drug Addiction Treatment Act of 2000 requires physicians to combine medication-assisted treatment (MAT) with behavioral intervention, there is no clear evidence for what form or elements of psychotherapy are most effective when coupled with MAT to treat OUD. This investigation involves focus groups designed to collect patient opinions about a specific psychotherapy, called START NOW, as well as general beliefs about various elements of psychotherapy for treating OUD. Our analysis reveals trends about patient preferences and strategies for improving OUD treatment.

methodsSubjects included patients enrolled in buprenorphine/naloxone MAT at our institution's office-based opioid treatment program. All subjects participated in a single START NOW group session, which was led by a provider (physician or nurse practitioner trained and standardized in delivering START NOW). Consented subjects participated in satisfaction surveys and audio-recorded focus groups assessing individual beliefs about various elements of psychotherapy for treating OUD.

resultsOverall, 38 different focus groups, 92 participation events, and 44 unique subjects participated in 1-to-6 different START NOW session/audio-recorded focus group sessions led by a certified moderator. Demographic data from 36/44 subjects was collected. Seventy-five percent (33/44) completed the START NOW Assessment Protocol, which revealed self-reported behavioral trends. Analysis of all 92 START NOW Satisfaction Questionnaire results suggests that subjects' opinions about START NOW improved with increased participation. Our analysis of audio-recorded focus groups is divided into three subsections: content strategies for new psychotherapies, implementation strategies, and other observations. For example, participants request psychotherapies to target impulsivity and to teach future planning and build positive relationships.

conclusionsThe results of this study may guide implementation of psychotherapy and improve the treatment of OUD, especially as it relates to improving the modified START NOW program for treating OUD. Our study also reveals a favorable outlook of START NOW with increased participation, suggesting that any initial reticence to this program can be overcome to allow for effective implementation.

Indexed as

BuprenorphineOpioid-Related DisordersAnalgesics, OpioidFocus GroupsHumansNeeds AssessmentOpiate Substitution TreatmentAnalgesics, OpioidBuprenorphineImplementation scienceMedication-assisted treatmentOffice-based opioid treatmentOpioid use disorder

Identifiers

PMID33423661
PMCPMC7798217
OpenAlexW3118471989

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.